AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira, ...
The Polaris Global Equity Composite gained 5.04% (net of fees) for the quarter, while the MSCI World Index returned 7.36%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback